High-throughput approaches to sourcing of human hepatocytes for cell-based therapies
Year: 2014
Type: dissertation
Abstract: Chronic liver disease affects more than 500 million people worldwide. The only therapy shown to directly prevent mortality is organ transplantation. However, there is growing discrepancy between supply and demand of transplant-grade organs and transplant recipients are subject to a lifetime of immunosuppressive regimens. Therefore, the overall aim of this thesis is to advance alternatives to whole organ transplantation for liver diseases. Treating the failure of organs serving a multitude of biochemical functions, such as the liver, requires cell-based therapies. Such therapies should ideally employ human cells due to immunological concerns and the substantial differences between animal and human hepatocellular functions. Human cell lines, while renewable, lack the full functional capacity of primary adult hepatocytes, and for clinical applications there is a tumorigenic risk. Primary human hepatocytes have exhibited therapeutic potential; however, limited sourcing has been a
Author: Jing Shan
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1482083015
